Related Experiment Videos
Long-term intervention studies using insulin in patients with type 1 diabetes
1Department of Medicine, University of Perugia, Italy.
Summary
Intensive insulin therapy, including insulin pump use or analogues, can prevent hypoglycemia and improve glycemic control in type 1 diabetes patients. This approach allows for safe achievement and maintenance of target blood sugar levels.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Type 1 diabetes affects over 10 million people globally, with traditional insulin regimens often leading to hypoglycemia.
- Hypoglycemia unawareness is a significant complication, but it is largely reversible.
Purpose of the Study:
- To review long-term intervention data for type 1 diabetes therapy.
- To discuss strategies for hypoglycemia prevention and safe glycemic goal achievement.
Main Methods:
- Elucidation of shortcomings in traditional insulin therapy models.
- Emphasis on the necessity of physiologic insulin replacement.
Main Results:
- Twice-daily insulin injections, while common, contribute significantly to hypoglycemia and unawareness.
- Intensive insulin therapy, including continuous subcutaneous insulin infusion (insulin pump) or insulin glargine, can prevent hypoglycemia and maintain glycemic targets.
- Rapid- and long-acting insulin analogues in intensive protocols improve glycemic control and reduce hypoglycemia risk.
Conclusions:
- Safe achievement and maintenance of target glycemic goals are attainable with modern insulin analogues and intensive management.
- Physiologic insulin replacement strategies are crucial for optimizing type 1 diabetes care.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...